Skip to main content
. Author manuscript; available in PMC: 2014 Jun 25.
Published in final edited form as: Best Pract Res Clin Endocrinol Metab. 2012 Apr;26(2):189–201. doi: 10.1016/j.beem.2011.09.002

Table 1.

Thirty-eight genetic variants associated with type 2 diabetes (T2D) at genome-wide significance.

Locus Marker Chr Type of variant Risk allele/
other allele
Risk allele
frequency
OR for T2D (95% CI)
KCNQ1 rs223789274 a 11 Intronic C/T 0.61b 1.40 (1.34–1.47)
TCF7L2 rs79031469 10 Intronic T/C 0.25 1.37 (1.28–1.47)18
DUSP9 rs594532619 X 8 kb upstream G/A 0.12 1.27 (1.18–1.37)
CDKN2A/B rs108116611517 9 125 kb upstream T/C 0.79 1.20 (1.14–1.25)
IRS1 rs294364175 2 502 kb upstream C/T 0.61 1.19 (1.13–1.25)
IGF2BP2 rs44029601517 3 Intronic T/G 0.29 1.17 (1.10–1.25)18
FTO rs805013615, 16 16 Intronic A/C 0.45 1.15 (1.09–1.22)18
KCNJ11/ABCC8 rs5219c/rs75711012 c 11 Missense:Glu23Lys/Ala1369Ser T/C 0.50 1.15 (1.09–1.21)17
G/T 0.40
THADA rs757859718 2 Missense: Thr1187Ala T/C 0.92 1.15 (1.10–1.20)
CENTD2 rs155222419 11 5′ UTR A/C 0.88 1.14 (1.11–1.17)
PPARG rs180128211 3 Missense: Pro12Ala C/G 0.92 1.14 (1.08–1.20)1517
HHEX rs111187514 10 7.7 kb downstream C/T 0.56 1.13 (1.08–1.17)17
NOTCH2 rs1092393118 1 Intronic T/G 0.11 1.13 (1.08–1.17)
WFS1 rs180121419 4 Intron-exon junction G/A 0.27 1.13 (1.07–1.18)
ADCY5 rs1170806776 3 Intronic A/G 0.78 1.12 (1.09–1.15)
CDKAL1 rs77548401517 6 Intronic C/G 0.31 1.12 (1.08–1.16)
HNF1B rs75721077, 78 17 Intronic A/G 0.43 1.12 (1.07–1.18)19
SLC30A8 rs1326663414 8 Missense: Arg325Trp C/T 0.75 1.12 (1.07–1.16)19
CDC123/CAMK1D rs1277979018 10 Intergenic region G/A 0.23 1.11 (1.07–1.14)
RBMS1/ITGB6 rs759373079 2 Intronic C/T 0.57 1.11 (1.08–1.16)
TLE4 rs1329213619 9 234 kb upstream C/T 0.93 1.11 (1.07–1.15)
HMGA2 rs153134319 12 43 kb upstream C/G 0.10 1.10 (1.07–1.14)
JAZF1 rs86474518 7 Intronic T/C 0.52 1.10 (1.07–1.13)
ADAMTS9 rs460710318 3 38 kb upstream C/T 0.81 1.09 (1.06–1.12)
MTNR1B rs1083096376 11 Intronic G/C 0.30 1.09 (1.06–1.12)
TSPAN8/LGR5 rs796158118 12 Intronic C/T 0.23 1.09 (1.06–1.12)
BCL11A rs24302119 2 99 kb downstream A/G 0.46 1.08 (1.06–1.10)
KCNQ1 rs23136219 a 11 Intronic G/A 0.52 1.08 (1.06–1.10)
ZBED3 rs445705319 5 41 kb upstream G/A 0.26 1.08 (1.06–1.11)
GCK rs460751776 7 36 kb upstream A/G 0.20 1.07 (1.05–1.10)
KLF14 rs97228319 7 47 kb upstream G/A 0.55 1.07 (1.05–1.10)
OASL/HNF1A rs795719719 12 20 kb downstream T/A 0.85 1.07 (1.05–1.10)
PRC1 rs804268019 15 Intronic A/C 0.22 1.07 (1.05–1.09)
PROX1 rs34087476 1 2 kb upstream C/T 0.50 1.07 (1.05–1.09)
DGKB/TMEM195 rs219134976 7 Intergenic region T/G 0.47 1.06 (1.04–1.08)
GCKR rs78009476 2 Intronic C/T 0.62 1.06 (1.04–1.08)
TP53INP1 rs89685419 8 Intronic T/C 0.48 1.06 (1.04–1.09)
ZFAND6 rs1163439719 15 1.5 kb downstream G/A 0.56 1.06 (1.04–1.08)

SNPs are ordered by odds ratio (OR) for T2D. Reference for each SNP is from the original report, and OR for T2D is from that reference cited unless otherwise noted. Risk allele frequencies are from HapMap CEU unless otherwise noted. Chr, chromosome. CI, confidence interval. kb, kilobase. Adapted from Billings LK, Florez JC. Ann NY Acad Sci. 2010 Nov; 1212:59–77.

a

These SNPs are in low linkage disequilibrium (LD) in Europeans (r2 = 0.01) and likely represent independent association signals.

b

Risk allele frequency from HapMap-JPT.

c

These two SNPs are in strong LD in adjacent genes in Europeans (r2 = 0.87).